Related Experiment Video

Updated: Feb 23, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

MicroRNA Let-7g Directly Targets Forkhead Box C2 (FOXC2) to Modulate Bone Metastasis in Breast Cancer

Lei Wang1, Ming Li2, Yongxin Zhou1

  • 1Department of Orthopaedics, The First Affiliated Hospital of Xi'an Medical University, Xi'an710077, China.

Open Medicine (Warsaw, Poland)
|September 13, 2017
PubMed

Insights

Reduced let-7g microRNA levels correlate with increased breast cancer bone metastasis. Let-7g suppresses cancer cell migration by targeting the FOXC2 gene, offering new insights into metastasis mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of gene expression implicated in various cancers.
  • Reduced levels of the let-7g miRNA have been observed in breast cancer tissues.
  • The specific role of let-7g in breast cancer bone metastasis remains largely unexplored.

Purpose of the Study:

  • To investigate the significance of let-7g in breast cancer bone metastasis.
  • To identify novel target genes of let-7g involved in this process.
  • To elucidate the molecular mechanisms underlying let-7g's function in bone metastasis.

Main Methods:

  • Quantitative real-time Polymerase Chain Reaction (qRT-PCR) to measure let-7g and FOXC2 expression in clinical samples.
  • Transfection experiments with let-7g mimics or inhibitors in breast cancer cell lines (MDA-MB-231, SK-BR3).
  • Western blot analysis to assess protein levels and wound healing assays to evaluate cell migration, alongside FOXC2 RNA interference (RNAi).

Main Results:

  • FOXC2 expression was elevated in breast cancer tissues with bone metastasis compared to non-cancerous tissues.
  • Let-7g expression was inversely correlated with FOXC2 levels in metastatic breast cancer samples.
  • Enforced let-7g expression decreased FOXC2 protein levels, while let-7g inhibition increased them.
  • Let-7g inhibition promoted cell migration, an effect reversed by FOXC2 RNAi.

Conclusions:

  • Let-7g acts as a tumor suppressor by inhibiting cell migration in breast cancer.
  • FOXC2 is a direct target gene of let-7g, mediating its suppressive effects on migration.
  • These findings provide novel insights into the molecular mechanisms of breast cancer bone metastasis and suggest potential therapeutic targets.
Keywords:
Bone metastasisBreast cancerFOXC2Migrationlet-7g

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

819
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K